High Content Analysis using Stem Cells for Disease Modelling and Drug Discovery Davide Danovi, Director, Kings College London, speaking at Stem Cells in Drug Discovery.
Developing Predictive Hepatocyte Models from Pluripotent Stem Cells David Hay, Principal Investigator, MRC Centre for Regenerative Medicine, speaking at Stem Cells in Drug Discovery.
Practicalities of Automating Human Interaction with Robotic Cells This webinar will look at the use of industrial robots in work cells where operators need to load and unload products from the robots working area and what safety preclusions and solutions are available.
Human ESC-derived Cardiomyocytes Michael Clements, Scientist, GE Healthcare, speaking at Stem Cells in Drug Discovery.
Disease Modelling and Drug Discovery in Neurological Disorders Zameel Cader, Director and Principal Scientist, IMI StemBANCC, University of Oxford, speaking at Stem Cells in Drug Discovery.
Cardiac iPSCs for Drug Discovery Joseph Wu, Director, Stanford Cardiovascular Institute, speaking at Stem Cells in Drug Discovery.
Novel Technology Approaches for Capture and Characterization of Circulating Tumor Cells Henry Lin,Graduate Student, University of California, speaking at CellTech 2013.
A Novel Vertically-Integrated Platform for the Discovery and Molecular Characterization of Lung Cancer Stem Cells Raj Batra, University of California Los Angeles, speaking at Diagnostics & Biomarkers 2015.
Phenotypic Profiling in a Physiologically Relevant Cell System Mohanraj Dhanabal, EMD Serono Inc, speaking at Drug Discovery and Development 2014
iPS-based Automated Drug Screening: From Human iPS to Midbrain Dopaminergic Neurons Jan Bruder, Max Planck Institute Münster, speaking at Advances in Automation & Robotics 2014